COMMUNIQUÉS West-GlobeNewswire

Summit Therapeutics to Present at H. C. Wainwright & Co. Global Life Sciences Conference
02/04/2019
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Therapeutics to Present at H. C. Wainwright & Co. Global Life Sciences Conference Oxford, UK, and Cambridge, MA, US, 2 April 2019 – Summit Therapeutics plc [...]
Zealand Pharma to attend Needham Healthcare Conference
02/04/2019
Press release – No. 06 / 2019 Zealand Pharma to attend Needham Healthcare Conference Copenhagen, April 2, 2019 – Adam Steensberg, Interim Chief Executive Officer, and Marino Garcia, Senior Vice President of Corporate [...]
G1 Therapeutics to Present at the 18th Annual Needham Healthcare Conference
02/04/2019
RESEARCH TRIANGLE PARK, N.C., April 02, 2019 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced Chief Executive Officer Mark Velleca, M.D., Ph.D., will present a [...]
Aptose to Present at the H.C. Wainwright Annual Global Life Sciences Conference
02/04/2019
SAN DIEGO and TORONTO, April 02, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of [...]
IRADIMED CORPORATION Announces FDA 510(k) Clearance for Neonatal Pulse Oximetry and Capnography Monitoring Using its MRI-Compatible Patient Vital Signs Monitor
02/04/2019
WINTER SPRINGS, Fla., April 02, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), today announced that it received FDA 510(k) clearance for neonatal use of the pulse oximetry (“SpO2”) and Capnography (“CO2 [...]
Idera Pharmaceuticals Presents ILLUMINATE-101 Data Demonstrating Tilsotolimod Activates Innate and Adaptive Immunity as Monotherapy in Patients with Refractory Solid Tumors at the American Association for Cancer Research (AACR) 2019 Annual Meeting
02/04/2019
– Tilsotolimod activated IFN-α and MHC class II genes in the tumor microenvironment across multiple tumor types – EXTON, Pa., April 02, 2019 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ: IDRA), a [...]
EyePoint Pharmaceuticals to Present at Upcoming Investor Conferences
02/04/2019
WATERTOWN, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]
Molecular Templates’ Presentations at the American Association of Cancer Research (AACR) Annual Meeting 2019 Highlight Evolution of ETB Platform
02/04/2019
Presentations from multiple pipeline programs feature data demonstrating continued evidence of forced internalization with CD38 and PD-L1 leads, dramatically improved tolerability in NHP models, enhanced potency, and [...]
Trillium Therapeutics Expands Immuno-Oncology Pipeline With STING Agonist Program
02/04/2019
- Preclinical data presented at the 2019 AACR Annual Meeting TORONTO, April 02, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (Nasdaq/TSX: TRIL), a clinical-stage immuno-oncology company developing innovative [...]
Arvinas Strengthens Management Team with Internal Appointments of Andy Crew, Ph.D. as Chief Technology Officer and Ian Taylor, Ph.D. as Chief Scientific Officer
02/04/2019
NEW HAVEN, Conn., April 02, 2019 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a biopharmaceutical company creating a new class of therapies that degrades disease-causing proteins, announced that two members of the [...]
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
02/04/2019
THE WOODLANDS, Texas, April 02, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Lonnel Coats, President and Chief Executive Officer, will present at the following conference: [...]
ContraFect Announces CEO Transition
02/04/2019
Dr. Roger J. Pomerantz appointed Chairman and CEO Dr. Steven C. Gilman retires and remains on board as Vice Chairman YONKERS, New York, April 02, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a [...]
Nabriva Therapeutics to Present at the Needham and Company 18th Annual Healthcare Conference
02/04/2019
DUBLIN, Ireland and KING OF PRUSSIA, Pa., April 02, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the development of innovative anti-infective agents to treat [...]
Athenex Announces Appointment of John Koh as a New Board Member
02/04/2019
BUFFALO, N.Y., April 02, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Unum Therapeutics to Present at Two Upcoming Investor Conferences
02/04/2019
CAMBRIDGE, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies to treat cancer based on its [...]
Innovate Biopharmaceuticals to Announce First Quarter 2019 Financial Results and to Provide Operational Progress Updates on April 29, 2019
02/04/2019
Innovate plans to provide an operational progress update, including regarding its first phase 3 celiac disease clinical trial Topline NASH preclinical data expected to be released at the Digestive Disease Week (DDW) [...]
Meridian Bioscience Announces Preliminary Second Quarter 2019 Revenue Results; Updates Fiscal 2019 Guidance
02/04/2019
CINCINNATI, April 02, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today provided a business update including preliminary [...]
LHC Group and Geisinger finalize joint venture agreement for home health and hospice services in Pennsylvania
02/04/2019
LAFAYETTE, La. and DANVILLE, Pa., April 02, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) and Geisinger Home Health and Hospice finalized a previously announced joint venture partnership to enhance home health [...]
MannKind to Present at the H.C. Wainwright Global Life Sciences Conference
02/04/2019
WESTLAKE VILLAGE, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases [...]

Pages